Abstract Library

#2945 Misdiagnosis of Pancreatic Neuroendocrine Carcinoma - A Potential Threat

Introduction: Pancreatic neuroendocrine tumors (PNETs) are a rare clinical entity.Very less data is available in Pakistan on PNETs.Common metastatic sites are liver, lung and brain Reports involving metastasis to breast are almost negligible.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Athar A,

Keywords: Breast Carcinoma, PNETs, Misdiagnosis,

#1592 Primary Neuroendocrine Carcinoma of the Breast: A Diagnostic Approach to the Special Type of Breast Malignancy

Introduction: WHO classification from 2003 defines primary neuroendocrine carcinomas (NEC) of the breast as a group of tumors with expression of neuroendocrine markers in more than 50% of tumor cells. In the current WHO classification this category is renamed to “carcinomas with neuroendocrine features” without defined clear-cut of the percentage of tumor cells positive for neuroendocrine markers.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Demirovic A

Authors: Demirović A, Vranic S, Skenderi F, Peric Balja M, Ulamec M,

Keywords: breast cancer, special types, carcinoma with neuroendocrine features, neuroendocrine markers,

#716 Adrenal Metastases and Neuroendocrine Breast Carcinoma in a MEN-1 Patient

Introduction: In Multiple Endocrine Neoplasia type 1 (MEN-1) pituitary, parathyroid and pancreatic/duodenal endocrine cells are typically involved. Other neoplasms also occur.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Pasquali C

Authors: Moletta L, Milanetto A, Sperti C, Alaggio R, Pedrazzoli S,

Keywords: MEN-1 syndrome, breast cancer, adrenal metastasis, rare tumors,

#103 From hormone dependent solid breast carcinoma to primary neuroendocrine carcinoma: a case report

Introduction: Primary neuroendocrine carcinoma of the breast is an extremely rare tumor with incidence of 0.27-0.5%.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Macut D, Kecman G, Bogavac T, Popovic B, Bozic I,

Keywords: neuroendocrine carcinoma, breast carcinoma, hormonal therapy,